FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2323589075> ?p ?o ?g. }

• W2323589075 endingPage "1133" @default.
• W2323589075 startingPage "1123" @default.
• W2323589075 abstract "Higher-than-normal levels of circulating triglycerides are a risk factor for ischemic cardiovascular disease. Activation of lipoprotein lipase, an enzyme that is inhibited by angiopoietin-like 4 (ANGPTL4), has been shown to reduce levels of circulating triglycerides.We sequenced the exons of ANGPTL4 in samples obtain from 42,930 participants of predominantly European ancestry in the DiscovEHR human genetics study. We performed tests of association between lipid levels and the missense E40K variant (which has been associated with reduced plasma triglyceride levels) and other inactivating mutations. We then tested for associations between coronary artery disease and the E40K variant and other inactivating mutations in 10,552 participants with coronary artery disease and 29,223 controls. We also tested the effect of a human monoclonal antibody against ANGPTL4 on lipid levels in mice and monkeys.We identified 1661 heterozygotes and 17 homozygotes for the E40K variant and 75 participants who had 13 other monoallelic inactivating mutations in ANGPTL4. The levels of triglycerides were 13% lower and the levels of high-density lipoprotein (HDL) cholesterol were 7% higher among carriers of the E40K variant than among noncarriers. Carriers of the E40K variant were also significantly less likely than noncarriers to have coronary artery disease (odds ratio, 0.81; 95% confidence interval, 0.70 to 0.92; P=0.002). K40 homozygotes had markedly lower levels of triglycerides and higher levels of HDL cholesterol than did heterozygotes. Carriers of other inactivating mutations also had lower triglyceride levels and higher HDL cholesterol levels and were less likely to have coronary artery disease than were noncarriers. Monoclonal antibody inhibition of Angptl4 in mice and monkeys reduced triglyceride levels.Carriers of E40K and other inactivating mutations in ANGPTL4 had lower levels of triglycerides and a lower risk of coronary artery disease than did noncarriers. The inhibition of Angptl4 in mice and monkeys also resulted in corresponding reductions in these values. (Funded by Regeneron Pharmaceuticals.)." @default.
• W2323589075 created "2016-06-24" @default.
• W2323589075 creator A5008058230 @default.
• W2323589075 creator A5011523298 @default.
• W2323589075 creator A5013355675 @default.
• W2323589075 creator A5016277597 @default.
• W2323589075 creator A5020019979 @default.
• W2323589075 creator A5020107496 @default.
• W2323589075 creator A5023169260 @default.
• W2323589075 creator A5024158146 @default.
• W2323589075 creator A5025311418 @default.
• W2323589075 creator A5026393136 @default.
• W2323589075 creator A5027472502 @default.
• W2323589075 creator A5032100711 @default.
• W2323589075 creator A5044370499 @default.
• W2323589075 creator A5054806120 @default.
• W2323589075 creator A5057175194 @default.
• W2323589075 creator A5057563096 @default.
• W2323589075 creator A5060327440 @default.
• W2323589075 creator A5065704891 @default.
• W2323589075 creator A5066636070 @default.
• W2323589075 creator A5074651593 @default.
• W2323589075 creator A5080002702 @default.
• W2323589075 creator A5081769614 @default.
• W2323589075 creator A5085672493 @default.
• W2323589075 creator A5085974594 @default.
• W2323589075 creator A5088758683 @default.
• W2323589075 creator A5089863056 @default.
• W2323589075 date "2016-03-24" @default.
• W2323589075 modified "2023-10-17" @default.
• W2323589075 title "Inactivating Variants in <i>ANGPTL4</i> and Risk of Coronary Artery Disease" @default.
• W2323589075 cites W1919257374 @default.
• W2323589075 cites W1944135887 @default.
• W2323589075 cites W1976428272 @default.
• W2323589075 cites W1993493243 @default.
• W2323589075 cites W2006056606 @default.
• W2323589075 cites W2013416277 @default.
• W2323589075 cites W2020915011 @default.
• W2323589075 cites W2026462049 @default.
• W2323589075 cites W2028558940 @default.
• W2323589075 cites W2033151532 @default.
• W2323589075 cites W2036747551 @default.
• W2323589075 cites W2042140336 @default.
• W2323589075 cites W2042869855 @default.
• W2323589075 cites W2050838276 @default.
• W2323589075 cites W2052644460 @default.
• W2323589075 cites W2058148991 @default.
• W2323589075 cites W2061100095 @default.
• W2323589075 cites W2075357023 @default.
• W2323589075 cites W2088403686 @default.
• W2323589075 cites W2097893773 @default.
• W2323589075 cites W2103504539 @default.
• W2323589075 cites W2105521580 @default.
• W2323589075 cites W2106578986 @default.
• W2323589075 cites W2106937178 @default.
• W2323589075 cites W2111563461 @default.
• W2323589075 cites W2116015900 @default.
• W2323589075 cites W2117617326 @default.
• W2323589075 cites W2118471945 @default.
• W2323589075 cites W2119180969 @default.
• W2323589075 cites W2129606778 @default.
• W2323589075 cites W2136342596 @default.
• W2323589075 cites W2139327524 @default.
• W2323589075 cites W2145813488 @default.
• W2323589075 cites W2146750742 @default.
• W2323589075 cites W2150874658 @default.
• W2323589075 cites W2163534725 @default.
• W2323589075 cites W2163969089 @default.
• W2323589075 cites W2170009139 @default.
• W2323589075 cites W2247997571 @default.
• W2323589075 cites W2294822677 @default.
• W2323589075 doi "https://doi.org/10.1056/nejmoa1510926" @default.
• W2323589075 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4900689" @default.
• W2323589075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26933753" @default.
• W2323589075 hasPublicationYear "2016" @default.
• W2323589075 type Work @default.
• W2323589075 sameAs 2323589075 @default.
• W2323589075 citedByCount "379" @default.
• W2323589075 countsByYear W23235890752016 @default.
• W2323589075 countsByYear W23235890752017 @default.
• W2323589075 countsByYear W23235890752018 @default.
• W2323589075 countsByYear W23235890752019 @default.
• W2323589075 countsByYear W23235890752020 @default.
• W2323589075 countsByYear W23235890752021 @default.
• W2323589075 countsByYear W23235890752022 @default.
• W2323589075 countsByYear W23235890752023 @default.
• W2323589075 crossrefType "journal-article" @default.
• W2323589075 hasAuthorship W2323589075A5008058230 @default.
• W2323589075 hasAuthorship W2323589075A5011523298 @default.
• W2323589075 hasAuthorship W2323589075A5013355675 @default.
• W2323589075 hasAuthorship W2323589075A5016277597 @default.
• W2323589075 hasAuthorship W2323589075A5020019979 @default.
• W2323589075 hasAuthorship W2323589075A5020107496 @default.
• W2323589075 hasAuthorship W2323589075A5023169260 @default.
• W2323589075 hasAuthorship W2323589075A5024158146 @default.
• W2323589075 hasAuthorship W2323589075A5025311418 @default.
• W2323589075 hasAuthorship W2323589075A5026393136 @default.
• W2323589075 hasAuthorship W2323589075A5027472502 @default.

• next